| Assessment Status | Rapid Review complete |
| HTA ID | - |
| Drug | C1inhibitor (human) |
| Brand | Cinryze® |
| Indication | Treatment and pre-procedure prevention of angioedema attacks in adults and adolescents with hereditary angioedema (HAE). Routine prevention of angioedema attacks in adults and adolescents with severe and recurrent attacks of hereditary angioedema (HAE), who are intolerant to or insufficiently protected by oral prevention treatments, or patients who are inadequately managed with repeated acute treatment |
| Assessment Process | |
| Rapid review commissioned | 22/10/2012 |
| Rapid review completed | 14/11/2012 |
| Rapid review outcome | Full pharmacoeconomic assessment not recommended |
